Document Detail


Percutaneous nephrolithotomy in polycystic kidney disease: is it safe and effective?
MedLine Citation:
PMID:  22102138     Owner:  NLM     Status:  Publisher    
Abstract/OtherAbstract:
PURPOSE: Nephrolithiasis is common in patients with autosomal dominant polycystic kidney disease (ADPKD). Percutaneous management of nephrolithiasis is challenging because of a large number of parenchymal cysts and distorted calyceal anatomy. These patients also have varying grades of chronic kidney disease and are at increased risk of bleeding, which further increases the challenge. The objective of the study is to study the efficacy and safety of PCNL in ADPKD. MATERIALS AND METHODS: We retrospectively analyzed twenty-two patients of ADPKD with renal calculi managed by percutaneous nephrolithtomy (PCNL) from January 2000 to January 2010. Patients were divided into two groups: group I (serum creatinine ≤1.5 mg%), group II (serum creatinine >1.5 mg%). RESULTS: PCNL was done in 25 renal units among 22 patients. Sixteen patients had chronic kidney disease, and the average stone burden was 2.4 cm ± 0.8 cm. The overall success rate (complete stone clearance/residual fragments <4 mm) was 88% (22/25). Two patients required relook PCNL for residual stone and one required ESWL for the incomplete clearance. Mean preoperative serum creatinine in group I was 0.9 ± 0.1 mg% and in group II 3.1 ± 1.2 mg%. There was improvement in serum creatinine in group II (1.4 ± 0.5 mg%) postoperatively. Three patients required blood transfusion (13%) and four patients had fever postoperatively (18%). None of the patients required angioembolization. CONCLUSION: Despite the distorted calyceal anatomy and associated chronic kidney disease, PCNL is safe and effective in managing nephrolithiasis in polycystic kidney disease.
Authors:
Aneesh Srivastava; Rajesh Bansal; Alok Srivastava; Samit Chaturvedi; Priyadarshi Ranjan; M S Ansari; Abhishek Yadav; Rakesh Kapoor
Related Documents :
2044638 - Lovastatin and gemfibrozil in the treatment of type 2a and type 2b hyperlipoproteinemia.
22290558 - Hyperintense vessels on flair imaging in reversible cerebral vasoconstriction syndrome.
22914638 - Correlation between homocysteine serum levels and the duration of seizures in patients ...
22766998 - Risk factors for swallowing dysfunction in stroke patients.
22694718 - Microalbuminuria in non-diabetic stemi : an independent predictor for acute kidney injury.
2044638 - Lovastatin and gemfibrozil in the treatment of type 2a and type 2b hyperlipoproteinemia.
Publication Detail:
Type:  JOURNAL ARTICLE     Date:  2011-11-20
Journal Detail:
Title:  International urology and nephrology     Volume:  -     ISSN:  1573-2584     ISO Abbreviation:  -     Publication Date:  2011 Nov 
Date Detail:
Created Date:  2011-11-21     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  0262521     Medline TA:  Int Urol Nephrol     Country:  -    
Other Details:
Languages:  ENG     Pagination:  -     Citation Subset:  -    
Affiliation:
Department of Urology and Renal Transplant, SGPGIMS, Lucknow, India.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Non-compliance to the continuous ambulatory peritoneal dialysis procedure increases the risk of peri...
Next Document:  Reducing lipid peroxidation for improving colour stability of beef and lamb: on-farm considerations.